Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005694 | chromosome | 5 | 7 |
GO:0043226 | organelle | 2 | 7 |
GO:0043228 | non-membrane-bounded organelle | 3 | 7 |
GO:0043229 | intracellular organelle | 3 | 7 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 7 |
GO:0110165 | cellular anatomical entity | 1 | 7 |
GO:0005634 | nucleus | 5 | 1 |
GO:0005730 | nucleolus | 5 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: A4H3S7
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 7 |
GO:0006259 | DNA metabolic process | 4 | 7 |
GO:0006265 | DNA topological change | 5 | 7 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 7 |
GO:0006807 | nitrogen compound metabolic process | 2 | 7 |
GO:0006996 | organelle organization | 4 | 7 |
GO:0008152 | metabolic process | 1 | 7 |
GO:0009987 | cellular process | 1 | 7 |
GO:0016043 | cellular component organization | 3 | 7 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 7 |
GO:0043170 | macromolecule metabolic process | 3 | 7 |
GO:0044237 | cellular metabolic process | 2 | 7 |
GO:0044238 | primary metabolic process | 2 | 7 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 7 |
GO:0046483 | heterocycle metabolic process | 3 | 7 |
GO:0051276 | chromosome organization | 5 | 7 |
GO:0071103 | DNA conformation change | 6 | 7 |
GO:0071704 | organic substance metabolic process | 2 | 7 |
GO:0071840 | cellular component organization or biogenesis | 2 | 7 |
GO:0090304 | nucleic acid metabolic process | 4 | 7 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 7 |
GO:0006260 | DNA replication | 5 | 1 |
GO:0007059 | chromosome segregation | 2 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 7 |
GO:0003677 | DNA binding | 4 | 7 |
GO:0003824 | catalytic activity | 1 | 7 |
GO:0003916 | DNA topoisomerase activity | 3 | 7 |
GO:0003917 | DNA topoisomerase type I (single strand cut, ATP-independent) activity | 4 | 7 |
GO:0005488 | binding | 1 | 7 |
GO:0016853 | isomerase activity | 2 | 7 |
GO:0097159 | organic cyclic compound binding | 2 | 7 |
GO:0140097 | catalytic activity, acting on DNA | 3 | 7 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 7 |
GO:1901363 | heterocyclic compound binding | 2 | 7 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 123 | 127 | PF00656 | 0.609 |
CLV_NRD_NRD_1 | 92 | 94 | PF00675 | 0.628 |
CLV_PCSK_KEX2_1 | 92 | 94 | PF00082 | 0.628 |
CLV_PCSK_SKI1_1 | 165 | 169 | PF00082 | 0.558 |
CLV_PCSK_SKI1_1 | 66 | 70 | PF00082 | 0.668 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.619 |
DOC_CYCLIN_yCln2_LP_2 | 178 | 181 | PF00134 | 0.592 |
DOC_MAPK_DCC_7 | 69 | 77 | PF00069 | 0.511 |
DOC_MAPK_gen_1 | 203 | 213 | PF00069 | 0.388 |
DOC_PP2B_LxvP_1 | 178 | 181 | PF13499 | 0.592 |
DOC_PP4_MxPP_1 | 85 | 88 | PF00568 | 0.531 |
DOC_USP7_UBL2_3 | 214 | 218 | PF12436 | 0.312 |
DOC_WW_Pin1_4 | 19 | 24 | PF00397 | 0.471 |
DOC_WW_Pin1_4 | 3 | 8 | PF00397 | 0.723 |
DOC_WW_Pin1_4 | 31 | 36 | PF00397 | 0.520 |
DOC_WW_Pin1_4 | 70 | 75 | PF00397 | 0.506 |
LIG_14-3-3_CanoR_1 | 137 | 146 | PF00244 | 0.600 |
LIG_14-3-3_CanoR_1 | 233 | 239 | PF00244 | 0.388 |
LIG_14-3-3_CanoR_1 | 38 | 42 | PF00244 | 0.577 |
LIG_BRCT_BRCA1_1 | 246 | 250 | PF00533 | 0.231 |
LIG_CtBP_PxDLS_1 | 23 | 27 | PF00389 | 0.465 |
LIG_FHA_1 | 222 | 228 | PF00498 | 0.312 |
LIG_FHA_2 | 20 | 26 | PF00498 | 0.632 |
LIG_FHA_2 | 55 | 61 | PF00498 | 0.501 |
LIG_LIR_Nem_3 | 129 | 135 | PF02991 | 0.507 |
LIG_MYND_1 | 176 | 180 | PF01753 | 0.602 |
LIG_PDZ_Class_2 | 264 | 269 | PF00595 | 0.312 |
LIG_SH2_PTP2 | 229 | 232 | PF00017 | 0.312 |
LIG_SH2_SRC | 229 | 232 | PF00017 | 0.312 |
LIG_SH2_STAT5 | 229 | 232 | PF00017 | 0.312 |
LIG_SH3_3 | 177 | 183 | PF00018 | 0.516 |
LIG_SH3_3 | 5 | 11 | PF00018 | 0.628 |
LIG_UBA3_1 | 62 | 69 | PF00899 | 0.590 |
LIG_WW_3 | 179 | 183 | PF00397 | 0.506 |
MOD_CDC14_SPxK_1 | 73 | 76 | PF00782 | 0.508 |
MOD_CDK_SPxK_1 | 70 | 76 | PF00069 | 0.509 |
MOD_CDK_SPxxK_3 | 31 | 38 | PF00069 | 0.559 |
MOD_CK1_1 | 104 | 110 | PF00069 | 0.685 |
MOD_CK1_1 | 111 | 117 | PF00069 | 0.688 |
MOD_CK1_1 | 121 | 127 | PF00069 | 0.644 |
MOD_CK1_1 | 130 | 136 | PF00069 | 0.588 |
MOD_CK1_1 | 138 | 144 | PF00069 | 0.619 |
MOD_CK1_1 | 188 | 194 | PF00069 | 0.377 |
MOD_CK1_1 | 221 | 227 | PF00069 | 0.312 |
MOD_CK1_1 | 97 | 103 | PF00069 | 0.697 |
MOD_CK2_1 | 116 | 122 | PF00069 | 0.559 |
MOD_CK2_1 | 144 | 150 | PF00069 | 0.596 |
MOD_GlcNHglycan | 107 | 110 | PF01048 | 0.638 |
MOD_GlcNHglycan | 143 | 146 | PF01048 | 0.682 |
MOD_GlcNHglycan | 250 | 253 | PF01048 | 0.412 |
MOD_GlcNHglycan | 262 | 265 | PF01048 | 0.361 |
MOD_GSK3_1 | 103 | 110 | PF00069 | 0.708 |
MOD_GSK3_1 | 112 | 119 | PF00069 | 0.605 |
MOD_GSK3_1 | 122 | 129 | PF00069 | 0.640 |
MOD_GSK3_1 | 131 | 138 | PF00069 | 0.769 |
MOD_GSK3_1 | 218 | 225 | PF00069 | 0.312 |
MOD_GSK3_1 | 244 | 251 | PF00069 | 0.238 |
MOD_GSK3_1 | 33 | 40 | PF00069 | 0.497 |
MOD_GSK3_1 | 94 | 101 | PF00069 | 0.640 |
MOD_N-GLC_1 | 127 | 132 | PF02516 | 0.548 |
MOD_NEK2_1 | 222 | 227 | PF00069 | 0.312 |
MOD_NEK2_1 | 250 | 255 | PF00069 | 0.315 |
MOD_PIKK_1 | 1 | 7 | PF00454 | 0.521 |
MOD_PIKK_1 | 156 | 162 | PF00454 | 0.496 |
MOD_PKA_2 | 136 | 142 | PF00069 | 0.618 |
MOD_PKA_2 | 37 | 43 | PF00069 | 0.694 |
MOD_PKA_2 | 95 | 101 | PF00069 | 0.556 |
MOD_Plk_1 | 127 | 133 | PF00069 | 0.698 |
MOD_Plk_1 | 135 | 141 | PF00069 | 0.668 |
MOD_Plk_1 | 149 | 155 | PF00069 | 0.487 |
MOD_Plk_1 | 24 | 30 | PF00069 | 0.551 |
MOD_Plk_2-3 | 118 | 124 | PF00069 | 0.673 |
MOD_Plk_4 | 149 | 155 | PF00069 | 0.496 |
MOD_Plk_4 | 174 | 180 | PF00069 | 0.606 |
MOD_Plk_4 | 250 | 256 | PF00069 | 0.276 |
MOD_Plk_4 | 67 | 73 | PF00069 | 0.607 |
MOD_ProDKin_1 | 19 | 25 | PF00069 | 0.467 |
MOD_ProDKin_1 | 3 | 9 | PF00069 | 0.723 |
MOD_ProDKin_1 | 31 | 37 | PF00069 | 0.514 |
MOD_ProDKin_1 | 70 | 76 | PF00069 | 0.509 |
MOD_SUMO_rev_2 | 215 | 220 | PF00179 | 0.312 |
TRG_DiLeu_BaLyEn_6 | 49 | 54 | PF01217 | 0.519 |
TRG_ER_diArg_1 | 50 | 53 | PF00400 | 0.525 |
TRG_ER_diArg_1 | 91 | 93 | PF00400 | 0.628 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IID6 | Leptomonas seymouri | 62% | 100% |
A0A451EJV3 | Leishmania donovani | 79% | 100% |
A4HS02 | Leishmania infantum | 78% | 100% |
E9AJZ0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 79% | 100% |
Q95Z89 | Leishmania major | 80% | 97% |